BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22024941)

  • 1. Outcomes when cancer treatment is delivered on, or off, a clinical trial: implications for generalizability of study results.
    Markman M
    Oncology; 2011; 81(3-4):141-2. PubMed ID: 22024941
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Generalizability of trial results to elderly medicare patients with advanced solid tumors.
    Mol L; Koopman M; Ottevanger PB; Punt CJ
    J Natl Cancer Inst; 2015 Jun; 107(6):djv104. PubMed ID: 25952033
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of pancreatic carcinoma. Is there a role for radiotherapy and chemotherapy?
    Wils JA; Bleiberg H
    Acta Gastroenterol Belg; 1987; 50(1):114-20. PubMed ID: 2447729
    [No Abstract]   [Full Text] [Related]  

  • 4. Research in pancreatic cancer: an update after ASCO 2012.
    Saif MW
    JOP; 2012 Jul; 13(4):330-1. PubMed ID: 22797382
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of pancreatic carcinoma: therapeutic nihilism?
    Wils JA
    Recent Results Cancer Res; 1988; 110():87-94. PubMed ID: 3043600
    [No Abstract]   [Full Text] [Related]  

  • 6. Metformin for pancreatic cancer.
    Aung KL; Moore MJ
    Lancet Oncol; 2015 Jul; 16(7):748-9. PubMed ID: 26067686
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of therapeutic effect of chemotherapy with reference to clinical benefit response].
    Okada S
    Gan To Kagaku Ryoho; 2000 May; 27(5):696-701. PubMed ID: 10832437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic chemotherapy for unresectable pancreatic cancer].
    Naruge D; Nagashima F; Furuse J
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():148-51. PubMed ID: 25857004
    [No Abstract]   [Full Text] [Related]  

  • 9. Locally advanced non-metastatic pancreatic cancer--can we do more?
    Hawkins MA; Tait D
    Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):532-4. PubMed ID: 18614342
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapy in adenocarcinomas of the pancreas].
    Huguier M
    Gastroenterol Clin Biol; 2002 Nov; 26(11):1063; discussion 1063-4. PubMed ID: 12483149
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy of cancer of the exocrine pancreas].
    Bonneterre J
    Bull Cancer; 1990; 77(3):267-74. PubMed ID: 2140281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOLFIRINOX in locally advanced pancreatic cancer: the starting point for questioning.
    Levy A; Chargari C; Huguet F; VĂ©drine L; Deutsch E
    Pancreas; 2012 Aug; 41(6):973-4. PubMed ID: 22781912
    [No Abstract]   [Full Text] [Related]  

  • 13. [Postoperative adjuvant treatment for pancreatic cancer: present status and future perspective].
    Uesaka K; Kanemoto H; Sugiura T; Mizuno T; Okamura Y; Kinugasa Y; Bando E; Terashima M
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1403-5. PubMed ID: 21918335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonging survival in inoperable pancreatic cancer with combination chemotherapy.
    Goel AK; Seenu V
    Trop Gastroenterol; 1995; 16(2):141-3. PubMed ID: 8644365
    [No Abstract]   [Full Text] [Related]  

  • 15. Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986-2003.
    Meszoely IM; Wang H; Hoffman JP
    Surg Oncol Clin N Am; 2004 Oct; 13(4):685-96, x. PubMed ID: 15350942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of advanced pancreatic cancer with 5-fluorouracil, 4-epidoxorubicin and mitomycin C (FEM II). From the Chemotherapy of Gastrointestinal Tumors Group].
    Verhees S; Flechtner H; Queisser W; Heim ME; Fritz M; Trux F; Edler L
    Onkologie; 1990 Feb; 13(1):50-2. PubMed ID: 1692400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-drug conjugate may inhibit pancreatic cancer.
    Cancer Discov; 2013 Dec; 3(12):OF1. PubMed ID: 24327698
    [No Abstract]   [Full Text] [Related]  

  • 18. Elderly patients with advanced pancreatic cancer: the generalizability of the results of clinical trials to daily clinical practice.
    Giuliani J; Bonetti A
    Recenti Prog Med; 2017 Mar; 108(3):152-154. PubMed ID: 28398410
    [No Abstract]   [Full Text] [Related]  

  • 19. Erlotinib in pancreatic cancer patients: do we need more information from the NCIC CTG trial?
    MandalĂ  M; Moro C; Labianca R; Ferretti G
    J Clin Oncol; 2007 Sep; 25(27):4320-1; author reply 4321-2. PubMed ID: 17878488
    [No Abstract]   [Full Text] [Related]  

  • 20. FOLFIRINOX: a new standard treatment for advanced pancreatic cancer?
    Kim R
    Lancet Oncol; 2011 Jan; 12(1):8-9. PubMed ID: 21050812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.